Inventor · disambiguated record
Kin Tso
Also filed as: TSO KIN
55 granted patents·10 pending applications·444 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
65 records- 0197US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 0297US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0396US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 0496US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 0596US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 0695US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 0795US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 0895US8193197B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Jun 5, 2012·17 cites·38 claims
- 0994US7868013B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 11, 2011·25 cites·12 claims
- 1093US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 1191US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 1290US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 1389US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 1489US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 1589US8410093B2Cycloalkyl substituted pyrimidinediamine compounds and their usesLI HUI·Filed 2010·Granted Apr 2, 2013·9 cites·20 claims
- 1689US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1788US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 1888US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 1988US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 2088US9566278B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·6 cites·21 claims
- 2187US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 2287US9725419B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·7 cites·3 claims
- 2385US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 2485US9321763B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Apr 26, 2016·6 cites·64 claims
- 2585US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
- 2685US8377924B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·9 cites·31 claims
- 2784US11542259B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jan 3, 2023·3 cites·2 claims
- 2884US9732070B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 15, 2017·4 cites·27 claims
- 2983US10947216B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·28 claims
- 3083US10941140B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·2 cites·26 claims
- 3183US9682976B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·3 cites·55 claims
- 3283US9169249B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Oct 27, 2015·4 cites·17 claims
- 3383US8993585B2Cyclic amine substituted pyrimidinediamines as PKC inhibitorsSINGH RAJINDER·Filed 2008·Granted Mar 31, 2015·7 cites·29 claims
- 3482US11993594B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted May 28, 2024·0 cites·17 claims
- 3582US11939317B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 3681US9913843B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·3 cites·5 claims
- 3781US9593082B2Compositions and methods for inhibition of the JAK pathwayARGADE ANKUSH·Filed 2008·Granted Mar 14, 2017·3 cites·17 claims
- 3880US11827628B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·19 claims
- 3980US9149475B2Protein kinase C inhibitors and uses thereofRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Oct 6, 2015·5 cites·21 claims
- 4080US2022289776A1Pyrazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4179US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 4278US10414753B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·1 cites·29 claims
- 4378US10370367B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·1 cites·21 claims
- 4478US8334297B22,4-pyrimidinediamine compounds for treatment of inflammatory disordersLI HUI·Filed 2010·Granted Dec 18, 2012·5 cites·26 claims
- 4570US11667611B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 4670US11370808B2Pyrazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 28, 2022·0 cites·17 claims
- 4770US2024043414A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 4868US9040543B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·0 cites·17 claims
- 4964US8575165B2Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compoundsGURURAJA TARIKERE·Filed 2010·Granted Nov 5, 2013·2 cites·3 claims
- 5062US2007203161A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kin Tso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →